Skip to main content
W

Wai Chun Bio-Technology Limited — Investor Relations & Filings

Ticker · 660 HKEX Manufacturing
Open in API
Filings indexed 29 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 660

About Wai Chun Bio-Technology Limited

http://www.0660.hk

Wai Chun Bio-Technology Limited operates primarily as an investment holding company. Its principal business activities involve the manufacture and sale of modified starch and other biochemical products. The company also engages in general trading business.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong listing rules reporting a change in issued shares upon conversion of convertible bonds. It details the number of new shares issued, opening and closing balances and confirms compliance with listing rules. This is an announcement of a share capital change (new share issuance) rather than an interim or annual financial report. It fits the “Share Issue/Capital Change” category.
2026-04-27 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 24 APRIL 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the poll results at an Extraordinary General Meeting (EGM), detailing vote counts and the resolution outcome. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements.”
2026-04-24 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE MEMORANDUM OF UNDERSTANDING ON STRATEGIC COOPERATION FOR NEW ENERGY PROJECTS WITH VALUE OF US$50 BILLION
Regulatory Filings Classification · 1% confidence The document is a supplemental announcement filed on the Hong Kong Stock Exchange regarding a previously announced MOU for strategic cooperation on new energy projects. It provides additional project details and a financing framework but does not constitute an annual or interim report, earnings release, dividend notice, share issue, management change, M&A or takeover document, nor a transcript. It is a general regulatory update under the Listing Rules and does not fit more specific categories. Therefore, it should be classified as a Regulatory Filings (RNS) announcement.
2026-04-14 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings Classification · 1% confidence The document is an HKEX exchange notice announcing the resumption of trading in the company’s shares. It is neither a detailed corporate report nor an AGM/EGM voting result, but a general regulatory announcement. This falls under the fallback category “Regulatory Filings” (RNS).
2026-04-14 English
INSIDE INFORMATION - MEMORANDUM OF UNDERSTANDING ON STRATEGIC COOPERATION FOR NEW ENERGY PROJECTS WITH VALUE OF US$50 BILLION STRONG ALLIANCES WITH LEADING CENTRAL STATE-OWNED ENTERPRISES AND INTERNAT
Regulatory Filings Classification · 1% confidence The document is clearly an announcement made under the Hong Kong Listing Rules disclosing inside information about the signing of a Memorandum of Understanding for strategic cooperation on new energy projects. It is not an actual financial report (10-K, IR, ER), nor a proxy or remuneration statement, nor a dividend notice, share issuance, or M&A deal. It is a general regulatory announcement supplying material company news to the market and thus falls into the fallback category of Regulatory Filings (RNS).
2026-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.